Table 5.
Comparison of patients stratified by operative vs. non-operative treatment
| Operative (N=110, 56.4%) | Non-operative (N=85, 43.6%) | P value | |
| Demographics | |||
| Age, years | 69.1±7.6 | 73.4±9.2 | <0.001 | 
| Male | 84 (76.4%) | 53 (62.4%) | 0.04 | 
| Medical comorbidities | |||
| Diabetes mellitus | 26 (23.6%) | 22 (25.9%) | 0.74 | 
| Coronary artery disease | 19 (17.3%) | 11 (12.9%) | 0.43 | 
| COPD | 6 (5.5%) | 3 (3.5%) | 0.73 | 
| CVA/TIA | 6 (5.5%) | 4 (4.7%) | 1.00 | 
| Congestive heart failure | 2 (1.8%) | 2 (2.4%) | 1.00 | 
| CKD/ESRD | 4 (3.6%) | 7 (8.2%) | 0.22 | 
| ≥2 comorbidities | 17 (15.5%) | 8 (9.4%) | 0.28 | 
| Mechanism of injury | |||
| Fall—ground level | 21 (19.1%) | 39 (45.9%) | <0.001 | 
| Fall—height | 26 (23.6%) | 18 (21.2%) | 0.73 | 
| Motor vehicle collision | 58 (52.7%) | 23 (27%) | <0.001 | 
| Pedestrian struck | 4 (3.6%) | 4 (4.7%) | 0.73 | 
| Crush/industrial | 1 (0.9%) | 1 (1.2%) | 0.85 | 
| Any associated injury | 80 (72.7%) | 65 (76.5%) | 0.62 | 
| Any additional orthopedic injury | 63 (57.3%) | 51 (60%) | 0.77 | 
| Letournel classification | |||
| Posterior wall | 22 (20%) | 10 (11.8%) | 0.17 | 
| Posterior column | 0 (0%) | 1 (1.2%) | 0.90 | 
| Posterior wall+posterior column | 19 (17.3%) | 2 (2.4%) | <0.001 | 
| Transverse | 3 (2.7%) | 17 (20%) | <0.001 | 
| Transverse+posterior wall | 11 (10%) | 1 (1.2%) | 0.025 | 
| T-type | 8 (7.3%) | 5 (5.9%) | 0.92 | 
| Anterior wall | 1 (0.9%) | 2 (2.4%) | 0.82 | 
| Anterior column | 7 (6.4%) | 6 (7.1%) | 0.85 | 
| Anterior column posterior hemitransverse | 20 (18.2%) | 13 (15.3%) | 0.70 | 
| Associated both column | 19 (17.3%) | 28 (32.9%) | 0.018 | 
| Hip dislocation | 53 (48.2%) | 8 (9.4%) | <0.001 | 
| Femoral head injury | 13 (11.8%) | 1 (1.2%) | 0.01 | 
| Marginal impaction | 36 (32.7%) | 4 (4.7%) | <0.001 | 
| Any complication | 39 (35.5%) | 34 (40%) | 0.55 | 
Bold entries denote statistical significance.
CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; ESRD, end-stage renal disease; TIA, transient ischemic attack.